MolNFT v1 · #164370 · protein
Human myeloid-derived growth factor (mydgf)
6SVK: “Human myeloid-derived growth factor (mydgf)”. X-ray diffraction, 2 pockets (best druggability 0.77). MolNFT v1 #164370 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 6SVK
- Type
- protein
- Length
- 271 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Myeloid-derived growth factor
- UniProt
- Q969H8
- Pockets
- 2 · best druggability 0.77
Structure
x-ray diffraction · 2 distinct chains · 3% helix, 56% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Myeloid-derived growth factor | protein | 135 | 4% helix, 56% strand | Q969H8 |
| B | Myeloid-derived growth factor | protein | 136 | 2% helix, 55% strand | Q969H8 |
Ligands and binding sites
- MLI · Malonate ion · additive · chains B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 636 | 0.77 | 0.83 | 61 | empty |
| 2 | 180 | 0.48 | 0.76 | 28 | empty |
Interfaces
1 interface between chains.
- A–B · 933 Ų buried · 18 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 2 disulfide (disulfide).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q969H8
- Elsewhere: RCSB PDB 6SVK · PDBe 6SVK · UniProt Q969H8
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.